Clinical trial
A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With…
NCT00000925 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00000925 |
|---|---|
| Title | A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight Loss |
| Official title | Evaluation of High Protein Supplementation in HIV-1-Positive Subjects With Stable Weight Loss |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections, HIV Wasting Syndrome |
| Intervention type | Drug |
| Interventions | Optimune oral nutritional supplement |
| Enrollment | 56 |
| Start date | May 1, 1999 |
| Primary completion | Jun 1, 2003 |
| First posted | Aug 31, 2001 |
| Last update posted | Jul 29, 2013 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: